A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities

Trial Profile

A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Melatonin (Primary)
  • Indications Developmental disabilities; Sleep disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors NEURIM Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2016 Status changed from active, no longer recruiting to completed, as per a Neurim Pharmaceuticals media release.
    • 16 Nov 2016 This trial was carried out under EU-PIP and US-FDA IND, as reported by a Neurim Pharmaceuticals media release.
    • 02 Nov 2016 Results from this study will be presented at upcoming medical congresses, as reported by a Neurim Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top